
BATM have announced that it has developed a new method for the rapid and comprehensive diagnosis of tuberculosis (TB), which …

Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …

The US FDA has approved BPaL, the TB Alliance’s treatment for drug-resistant tuberculosis (TB). The US regulator gave the go-ahead …

The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …

Johnson and Johnson have announced that they are launching a 10-year initiative aimed at helping to end tuberculosis, the world’s …

Research conducted by the Francis Crick Institute has revealed how the body protects itself from Mycobacterium tuberculosis, the bacterium responsible …

The pharmaceuticals division at German-based Bayer will collaborate with the renowned medicinal chemistry and biology departments at the Universities of …
European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …

The European Medicines Agency has shown the green light to a new treatment for thyroid cancer and one for drug …

A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …

GlaxoSmithKline Vaccines has signed a deal with US not-for-profit biotech Aeras to develop a new vaccine which will treat tuberculosis …
Bill Gates has called on global leaders to invest in innovations that are accelerating progress against poverty, or risk a …
Lilly has launched a new open innovation platform designed to help build its pipeline and to identify new treatments for …

The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …